Concepedia

Publication | Open Access

Salvage Chemotherapy After Nivolumab for Recurrent or Metastatic Head and Neck Carcinoma

DOIFull Paper Access

36

Citations

17

References

2020

Year

Chihiro Fushimi, Isaku Okamoto, Takashi Matsuki, Tatsuo Masubuchi, Takuro Okada, Hiroki Sato, Kiyoaki Tsukahara, Takahito Kondo, Taku Yamashita, Kenji Hanyu,
Anticancer Research

Abstract

SCT after nivolumab is associated with better clinical outcomes in patients with R/M HNSCC compared to those receiving BSC.

References

YearCitations

Page 1